Saudi Arabia Center Advances Radiotherapy Technology with Nation's First Image Guided Cancer Treatment System from Elekta

For best results when printing this announcement, please click on the link
below:

http://pdf.reuters.com/pdfnews/pdfnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130109:nPnCL37912

King Abdulaziz University Hospital's Elekta Synergy boosts treatment speed for
patient comfort, integrates imaging for patient safety

JEDDAH, Saudi Arabia, Jan. 9, 2013 /PRNewswire/ -- In part to address the
12,000 new cancer cases annually in Saudi Arabia - many of them diagnosed at
an advanced stage - King Abdulaziz University Hospital is the first center
nationally to acquire image guided treatment technology from Elekta. The 700-bed
hospital launched a new era of advanced radiotherapy with the first clinical
treatments on its Elekta Synergy system in February 2012, offering patients
with difficult cases sophisticated Image Guided Radiation therapy (IGRT) and
Volumetric Modulated Arc Therapy (VMAT) for added precision and speed. The
hospital also acquired Elekta treatment planning systems in May 2012.

"Managing the planning and treatment of late stage cancers is challenging," says
Prof. Yasir Bahadur, M.D., Chairman of the Department of Radiology, under which
the Department of Radiation Oncology operates. "We needed user-friendly
technology that would allow us to accurately cover the target and protect normal
tissues, while treating our patients in a comfortable and timely manner. We
determined that Elekta Synergy met these needs from a technological standpoint."

The hospital had been operating two Siemens linear accelerators and added Elekta
Synergy because of its advanced technology, such as kilovoltage [kV] cone beam
CT [CBCT] and VMAT.

"While our whole radiotherapy practice has been image guided, the kV 3D
volumetric imaging of Elekta Synergy enables us to accurately deliver complex
treatment plans. The excellent quality of the kV treatment verification images -
versus the megavoltage [MV] images the other linacs produce - allows a clear
visualization of soft tissue structures without the need for implanted surrogate
markers."

With Elekta Synergy, King Abdulaziz University Hospital has, for the first time,
used VMAT in select cases, resulting in dramatic decreases in beam delivery time
compared to conventional techniques.

"The beam delivery time for VMAT is about five minutes, compared to nine minutes
for dynamic Intensity Modulated Radiation Therapy [IMRT] and 20 minutes for
step-and-shoot IMRT," Prof. Bahadur notes. "In addition, we have found that
delivery of IMRT is faster on Synergy versus our other systems.

"With Synergy," he continues, "we can easily treat 20 patients daily using
either VMAT or dynamic IMRT, with daily CBCT, during eight working hours, which
we were unable to do before. Now we can treat more patients and this has
shortened our waiting list."

In addition to Synergy, King Abdulaziz University Hospital also acquired
Elekta's XiO and Monaco treatment planning systems, and began using them
clinically in May 2012.

"We like the accuracy of the dose calculation algorithms and high speed
calculation of both treatment planning systems," Prof. Bahadur observes. "In
Monaco, we appreciate the biological modeling feature and the Sensitivity
Analysis tool that guide the planner through the plan optimization process."

As the hospital anticipates launching its new stereotactic radiation therapy
(SRT) service in February 2013, Prof. Bahadur looks forward to the same level
of Elekta support his team received in implementing advanced radiotherapy with
Elekta Synergy.

"We have been impressed by the outstanding standard of training activities
provided by Elekta to our staff," he remarks. "The professionalism of the
application specialists, in addition to their kindness and continuous support
are highly appreciated by the entire team. After nearly one year of using Elekta
Synergy in our department, we are confident and satisfied with the system, and
are very optimistic that with the launch of the SRT service, we will have
another opportunity to strengthen our collaboration and partnership."

In July 2010, King Abdulaziz University Hospital introduced Elekta's MOSAIQ
Oncology Information System as an upgrade of its LANTIS record & verify system,
and recently upgraded MOSAIQ to version 2.4.

"We find MOSAIQ very user-friendly and it integrated seamlessly with our Siemens
linacs," Prof. Bahadur says.

For further information, please contact:
Johan Andersson Melbi, Director, Investor Relations, Elekta AB
Tel: +46 702 100 451, email: johan.anderssonmelbi@elekta.com
Time zone: CET: Central European Time

Michelle Joiner, Director, Global Public Relations and Brand Management, Elekta

Tel: +1 770-670-2447, email: michelle.joiner@elekta.com
Time zone: ET: Eastern Time

About Elekta
Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated, state-of-the-art tools and treatment planning systems for
radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing
software systems across the spectrum of cancer care. Stretching the boundaries
of science and technology, providing intelligent and resource-efficient
solutions that offer confidence to both healthcare providers and patients,
Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000
hospitals worldwide. Elekta employs around 3,400 employees globally. The
corporate headquarters is located in Stockholm, Sweden, and the company is
listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.

SOURCE Elekta